Terms: = Bone cancer AND FGFR1, CEK, 2260, ENSG00000077782, P11362, FLT2, CD331, H3, HBGFR, FGFBR, H5, KAL2, H2, BFGFR, N-SAM, H4 AND Diagnosis
90 results:
1. A 50-Year-Old Man Presenting with Multiple bone Lesions and a diagnosis of Phosphaturic Mesenchymal Tumor of the Femur.
Ren D; Wei K; Ifegwu I
Am J Case Rep; 2024 Feb; 25():e942810. PubMed ID: 38361352
[TBL] [Abstract] [Full Text] [Related]
2. Giant Cell Tumor of the Acromion: Case Report and Literature Review.
Sano J; Chijiiwa Y; Nishio J
In Vivo; 2024; 38(1):506-510. PubMed ID: 38148094
[TBL] [Abstract] [Full Text] [Related]
3. Periosteal chondroblastoma of the femoral neck: two cases and a review of the literature.
Guillois C; Yang S; Biau D; Feydy A; Larousserie F
Skeletal Radiol; 2024 May; 53(5):1003-1009. PubMed ID: 37733062
[TBL] [Abstract] [Full Text] [Related]
4. H3F3A mutation as a marker of malignant giant cell tumor of the bone: A case report and review of literature.
Ratnagiri R; Uppin S
J Cancer Res Ther; 2023; 19(3):832-834. PubMed ID: 37470622
[TBL] [Abstract] [Full Text] [Related]
5. Utility of immunohistochemical expression of H3.3K36M and DOG1 in the diagnosis of chondroblastomas: An experience from a tertiary cancer referral center.
Rekhi B; Dave V; Butle A; Dutt A
Ann Diagn Pathol; 2023 Oct; 66():152174. PubMed ID: 37356274
[TBL] [Abstract] [Full Text] [Related]
6. Significance of Histone H3.3 (G34W)-Mutant Protein in Pathological diagnosis of Giant Cell Tumor of bone.
Miskad UA; Syamsul F; Dahlan H; Sungowati NK; Achmad D; Johan MP
Asian Pac J Cancer Prev; 2023 May; 24(5):1737-1741. PubMed ID: 37247296
[TBL] [Abstract] [Full Text] [Related]
7. Human cancer Cell Radiation Response Investigated through Topological Analysis of 2D Cell Networks.
Tirinato L; Onesto V; Garcia-Calderon D; Pagliari F; Spadea MF; Seco J; Gentile F
Ann Biomed Eng; 2023 Aug; 51(8):1859-1871. PubMed ID: 37093401
[TBL] [Abstract] [Full Text] [Related]
8. Giant cell tumor of bone with H3F3B mutation: A case report.
Wu R; Wu X; Weng X; Xiu Y; Xu G; Liu X; Liu X
Medicine (Baltimore); 2023 Feb; 102(7):e32995. PubMed ID: 36800629
[TBL] [Abstract] [Full Text] [Related]
9. Giant-cell-poor giant cell tumor of bone: report of two cases and literature review.
Yakoub MA; Torrence D; Hwang S; Bartelstein M; Healey JH; Hameed M
Skeletal Radiol; 2023 Sep; 52(9):1791-1798. PubMed ID: 36781420
[TBL] [Abstract] [Full Text] [Related]
10. bone and soft tissue tumors: clinicoradiologic-pathologic molecular-genetic correlation of novel fusion spindled, targetable-ovoid, giant-cell-rich, and round cell sarcomas.
Fanburg-Smith JC; Smith JD; Flemming DJ
Skeletal Radiol; 2023 Mar; 52(3):517-540. PubMed ID: 36542130
[TBL] [Abstract] [Full Text] [Related]
11. Molecular and immunohistochemical testing of bone tumours: review and update.
Kovacs SK; Manassaporn A; Nielsen GP; Hung YP
Histopathology; 2023 May; 82(6):794-811. PubMed ID: 36424903
[TBL] [Abstract] [Full Text] [Related]
12. Tumor-induced Osteomalacia: A Comprehensive Review.
Minisola S; Fukumoto S; Xia W; Corsi A; Colangelo L; Scillitani A; Pepe J; Cipriani C; Thakker RV
Endocr Rev; 2023 Mar; 44(2):323-353. PubMed ID: 36327295
[TBL] [Abstract] [Full Text] [Related]
13. Indolent presentation of a diffuse midline glioma, H3 K27-altered.
Damodharan S; Helgager J; Puccetti D
Childs Nerv Syst; 2023 Mar; 39(3):833-835. PubMed ID: 36094605
[TBL] [Abstract] [Full Text] [Related]
14. Distal Femoral Non-Epiphyseal Cortical Chondroblastoma Confirmed with
Gu H; Sun L; Cui J; Yu L; Wang J
Fetal Pediatr Pathol; 2023 Apr; 42(2):320-326. PubMed ID: 36048092
[No Abstract] [Full Text] [Related]
15. Anti-Histone H3.3 G34W antibody is a sensitive and highly specific immunohistochemistry marker for the diagnosis of Giant cell tumor of bone. A validation based on analysis of 198 cases from a single centre in India.
Kamble A; Hui M; Rao KN; Narayanan R; Reddy BR; Uppin SG; Chandrasekhar P
Indian J Pathol Microbiol; 2022; 65(3):617-629. PubMed ID: 35900490
[TBL] [Abstract] [Full Text] [Related]
16. Anti-histone H3.3K36M Antibody is a Highly Sensitive and Specific Immunohistochemistry Marker for the diagnosis of Chondroblastoma. A Validation Based on Study 136 Cases Comprising Chondroblastoma and its Mimics from Single a Centre in India.
Hui M; Uppin SG; Narayanan R; Kancherla NR; Kamble A; B RR; Patnala C
Int J Surg Pathol; 2023 Jun; 31(4):375-386. PubMed ID: 35786027
[No Abstract] [Full Text] [Related]
17. H3 K27M-mutant diffuse midline glioma with osseous metastases: A case report and a literature review.
Al Sharie S; Talafha M; Abu Laban D; Al Awabdeh T; Al-Mousa A; Al-Masri N; Al-Hussaini M
Clin Neuropathol; 2022; 41(6):263-270. PubMed ID: 35770519
[TBL] [Abstract] [Full Text] [Related]
18. Giant cell tumor of bone: An update, including spectrum of pathological features, pathogenesis, molecular profile and the differential diagnoses.
Rekhi B; Dave V
Histol Histopathol; 2023 Feb; 38(2):139-153. PubMed ID: 35766228
[TBL] [Abstract] [Full Text] [Related]
19. [Giant-cell tumor of bone in 2022].
Larousserie F; Audard V; Burns R; de Pinieux G
Ann Pathol; 2022 Apr; 42(3):214-226. PubMed ID: 35523609
[TBL] [Abstract] [Full Text] [Related]
20. Histological and immunohistochemical features and genetic alterations in the malignant progression of giant cell tumor of bone: a possible association with TP53 mutation and loss of H3K27 trimethylation.
Ishihara S; Yamamoto H; Iwasaki T; Toda Y; Yamamoto T; Yoshimoto M; Ito Y; Susuki Y; Kawaguchi K; Kinoshita I; Yamada Y; Kohashi K; Fujiwara T; Setsu N; Endo M; Matsumoto Y; Kakuda Y; Nakashima Y; Oda Y
Mod Pathol; 2022 May; 35(5):640-648. PubMed ID: 34785767
[TBL] [Abstract] [Full Text] [Related]
[Next]